InvestorsHub Logo
Followers 13
Posts 697
Boards Moderated 0
Alias Born 01/12/2013

Re: OPKOHEALTH2022 post# 120994

Monday, 01/04/2016 11:27:13 PM

Monday, January 04, 2016 11:27:13 PM

Post# of 130502
Market cap. is low due to OTC status and lack of credible funding. An Up listing to NASDAQ with meaningful funding will change that reality to at least $250-$350mm with Eltoprazine up and running.